Literature DB >> 22195399

PH2O and simulated hypobaric hypoxia.

Johnny Conkin1.   

Abstract

Some manufacturers of reduced oxygen (O2) breathing devices claim a comparable hypobaric hypoxia (HH) training experience by providing F1O2 < 0.209 at or near sea level pressure to match the ambient oxygen partial pressure (iso-PO2) of the target altitude. I conclude after a review of literature from investigators and manufacturers that these devices may not properly account for the 47 mmHg of water vapor partial pressure that reduces the inspired partial pressure of oxygen (P1O2), which is substantial at higher altitude relative to sea level. Consequently, some devices claiming an equivalent HH experience under normobaric conditions would significantly overestimate the HH condition, especially when simulating altitudes above 10,000 ft (3048 m). At best, the claim should be that the devices provide an approximate HH experience since they only duplicate the ambient PO2 at sea level as at altitude. An approach to reduce the overestimation and standardize the operation is to at least provide machines that create the same P1O2 conditions at sea level as at the target altitude, a simple software upgrade.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22195399     DOI: 10.3357/asem.3145.2011

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  7 in total

1.  Comments on Point:Counterpoint: Hypobaric hypoxia induces/does not induce different responses from normobaric hypoxia.

Authors:  Olivier Girard; Michael S Koehle; Martin J MacInnis; Jordan A Guenette; Michael S Koehle; Samuel Verges; Thomas Rupp; Marc Jubeau; Stephane Perrey; Guillaume Y Millet; Robert F Chapman; Benjamin D Levine; Johnny Conkin; James H Wessel; Hugo Nespoulet; Bernard Wuyam; Renaud Tamisier; Samuel Verges; Patrick Levy; Darren P Casey; Bryan J Taylor; Eric M Snyder; Bruce D Johnson; Abigail S Laymon; Jonathon L Stickford; Joshua C Weavil; Jack A Loeppky; Matiram Pun; Kai Schommer; Peter Bartsch; Mary C Vagula; Charles F Nelatury
Journal:  J Appl Physiol (1985)       Date:  2012-05

2.  The physiological effects of hypobaric hypoxia versus normobaric hypoxia: a systematic review of crossover trials.

Authors:  Jonny Coppel; Philip Hennis; Edward Gilbert-Kawai; Michael Pw Grocott
Journal:  Extrem Physiol Med       Date:  2015-02-26

3.  A Four-Way Comparison of Cardiac Function with Normobaric Normoxia, Normobaric Hypoxia, Hypobaric Hypoxia and Genuine High Altitude.

Authors:  Christopher John Boos; John Paul O'Hara; Adrian Mellor; Peter David Hodkinson; Costas Tsakirides; Nicola Reeve; Liam Gallagher; Nicholas Donald Charles Green; David Richard Woods
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

4.  A comparison of substrate oxidation during prolonged exercise in men at terrestrial altitude and normobaric normoxia following the coingestion of 13C glucose and 13C fructose.

Authors:  John P O'Hara; David R Woods; Adrian Mellor; Christopher Boos; Liam Gallagher; Costas Tsakirides; Nicola C Arjomandkhah; David A Holdsworth; Carlton B Cooke; Douglas J Morrison; Thomas Preston; Roderick Fgj King
Journal:  Physiol Rep       Date:  2017-01

5.  Effects of Dietary Nitrate Supplementation on Physiological Responses, Cognitive Function, and Exercise Performance at Moderate and Very-High Simulated Altitude.

Authors:  Oliver M Shannon; Lauren Duckworth; Matthew J Barlow; Kevin Deighton; Jamie Matu; Emily L Williams; David Woods; Long Xie; Blossom C M Stephan; Mario Siervo; John P O'Hara
Journal:  Front Physiol       Date:  2017-06-09       Impact factor: 4.566

Review 6.  Hypoxic Hypoxia and Brain Function in Military Aviation: Basic Physiology and Applied Perspectives.

Authors:  David M Shaw; Gus Cabre; Nicholas Gant
Journal:  Front Physiol       Date:  2021-05-17       Impact factor: 4.566

7.  Personalized medicine in human space flight: using Omics based analyses to develop individualized countermeasures that enhance astronaut safety and performance.

Authors:  Michael A Schmidt; Thomas J Goodwin
Journal:  Metabolomics       Date:  2013-06-27       Impact factor: 4.290

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.